TERT and meningioma: This held true when only comparing patients with and without preoperative seizures in the subgroup of meningiomas WHO grade 2 and 3 with available TERT promotor mutation status (OS: 65 versus 124 months, p = 0.805; RFS: 56 versus 34 months, p = 0.670).